Streetbeat News

Stock Prices

CYTK

NVS

Cytokinetics Inc (NASDAQ:CYTK) shares have risen due to reports of advanced takeover talks with Novartis AG (NYSE:NVS). The acquisition, potentially valued at around $9 billion, could be finalized soon but may still face uncertainties such as other bidders or deal collapse. The interest in Cytokinetics follows their promising trial results for aficamten, which boosted their stock by over 60% in December.

Portfolio Pulse from Vandana Singh

January 08, 2024 | 7:24 pm

EFX

BofA Securities analyst Heather Balsky upgraded Equifax Inc (NYSE:EFX) from Underperform to Buy and increased the price target from $164 to $300. The upgrade is based on the expectation of positive EPS revisions due to potential increases in mortgage originations and inquiries as interest rates ease. Equifax's stock has already risen 40% since the November 1 Fed meeting, and the analyst believes there is room for further growth. The new price target assumes an expansion of the earnings multiple from 21x to 27x, reflecting increased investor focus on the company's profitability potential for 2025. The Structured Finance team at BofA anticipates mortgage rates to drop from over 7% in 2023 to 6.0% by the end of 2024, which could lead to a 16-18% rise in originations. Equifax's USIS cloud transformation is also expected to contribute to wallet share gains over the next two years.

Portfolio Pulse from Shivani Kumaresan

January 08, 2024 | 7:10 pm

ALKT

CRM

WDAY

Software company stocks are trading higher due to a decrease in Treasury yields and positive announcements at CES 2024. This trend is affecting a broad range of companies within the sector.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 7:09 pm

LLAP

Terran Orbital's stock is trading lower following a downgrade by B. Riley Securities from Buy to Neutral, with a reduced price target from $2.5 to $1.35.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 7:04 pm

LINKUSD

Chainlink's (CRYPTO: LINK) price has risen by 5.07% in the last 24 hours to $14.21, despite an 8.0% decline over the past week from $15.46. The coin's all-time high is $52.70. Trading volume increased by 68.0%, and the circulating supply rose by 1.62% to 568.10 million, which is 56.81% of the max supply. LINK's market cap is now $8.07 billion, ranking it 14th.

Portfolio Pulse from Benzinga Insights

January 08, 2024 | 7:03 pm

CLRB

Cellectar Biosciences' stock is up following the announcement that its CLOVER WaM study successfully met its primary endpoint.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 7:03 pm

ADAUSD

Cardano's (CRYPTO: ADA) price has increased by 4.76% in the last 24 hours to $0.54, despite a 12% decline over the past week from $0.62. The coin's all-time high is $3.09. Trading volume has surged by 103% over the past week, and the circulating supply has grown by 0.09% to over 35.06 billion, which is 77.92% of the max supply. ADA's market cap is currently ranked #9 at $19.02 billion.

Portfolio Pulse from Benzinga Insights

January 08, 2024 | 7:02 pm

SOLUSD

Solana's (CRYPTO: SOL) price has increased by 3.99% in the last 24 hours, reaching $98.29, despite a weekly downtrend of 11%. The coin's all-time high is $259.96. Trading volume is up 61% over the week, while circulating supply decreased by 0.46%. Solana's market cap ranks it 5th at $42.62 billion.

Portfolio Pulse from Benzinga Insights

January 08, 2024 | 7:02 pm

ETHUSD

Ethereum (CRYPTO: ETH) has seen a 4.29% price increase in the last 24 hours, reaching $2,340.19, despite a 1.0% decline over the past week. The coin's all-time high is $4,878.26. Trading volume surged by 127.0%, while the circulating supply dropped by 0.61%. Ethereum currently holds the #2 market cap position at $282.16 billion.

Portfolio Pulse from Benzinga Insights

January 08, 2024 | 7:01 pm

BFLY

Butterfly Network's stock is trading higher following the announcement of FDA clearance for its new handheld ultrasound system, Butterfly iQ3.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 7:01 pm